Search research articles
Contact Us
Filters
Showing results (411-420 of 462) with videos related to
Page
of 47
Sort By:
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Mutant IDH impairs chromatin binding by PDGFB to promote chromosome instability
Rachel N Curry, Malcolm F McDonald, Peihao He, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 14, 2015
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
Anna F Farago, Long P Le, Zongli Zheng, et al.
Cancer Research
|
December 3, 2008
Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis
Shian-Ying Sung, Chia-Ling Hsieh, Andrew Law, et al.
The Journal of Clinical Investigation
|
July 12, 2008
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms
Zhi Gang Li, Paul Mathew, Jun Yang, et al.
Journal of Neurology
|
July 22, 2024
18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes
Anna Vasilevskaya, Chloe Anastassiadis, Simrika Thapa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2024
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide
Wassim Abida, Andrew W Hahn, Neal Shore, et al.
Cancers
|
October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
Nature Communications
|
January 3, 2024
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response
Mei Zhao, Tianxiao Wang, Frederico O Gleber-Netto, et al.
Cancer Discovery
|
November 30, 2018
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
Alexander Drilon, Siqing Fu, Manish R Patel, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 462) with videos related to
Sort By:
Page
of 47
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Mutant IDH impairs chromatin binding by PDGFB to promote chromosome instability
Rachel N Curry, Malcolm F McDonald, Peihao He, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 14, 2015
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
Anna F Farago, Long P Le, Zongli Zheng, et al.
Cancer Research
|
December 3, 2008
Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis
Shian-Ying Sung, Chia-Ling Hsieh, Andrew Law, et al.
The Journal of Clinical Investigation
|
July 12, 2008
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms
Zhi Gang Li, Paul Mathew, Jun Yang, et al.
Journal of Neurology
|
July 22, 2024
18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes
Anna Vasilevskaya, Chloe Anastassiadis, Simrika Thapa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2024
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide
Wassim Abida, Andrew W Hahn, Neal Shore, et al.
Cancers
|
October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
Nature Communications
|
January 3, 2024
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response
Mei Zhao, Tianxiao Wang, Frederico O Gleber-Netto, et al.
Cancer Discovery
|
November 30, 2018
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105
Alexander Drilon, Siqing Fu, Manish R Patel, et al.
Page
of 47